笠原佑記 (Yuki Kasahara) - マイポータル

基本情報

所属: 東北大学加齢医学研究所臨床腫瘍学分野助教

学位: 医学博士(2019年3月東北大学)

研究者番号: 50886562
J-GLOBAL ID: 202101018193571824
researchmap会員ID: R000024257

外部リンク: http://www.co.idac.tohoku.ac.jp

論文

Attenuated Li–Fraumeni syndrome with TP53 p.R181H in a Japanese patient with metastatic rectal adenocarcinoma: a case report

Yuki Kasahara, Masanobu Takahashi, Yoshifumi Kawamura, Yoko Aoki, Tetsuya Niihori, Maako Kawamura, Shinnosuke Yamamoto, Hidekazu Shirota, Ken Saijo, Hiroo Imai …

Familial Cancer 25(1) 2026年2月3日
Plasma Lysophosphatidylcholine Levels Correlate with Prognosis and Immunotherapy Response in Squamous Cell Carcinoma

Tomoyuki Iwasaki, Hidekazu Shirota, Eiji Hishinuma, Shinpei Kawaoka, Naomi Matsukawa, Yuki Kasahara, Kota Ouchi, Hiroo Imai, Ken Saijo, Keigo Komine …

International Journal of Molecular Sciences 26(15) 7528-7528 2025年8月4日
A retrospective study of pembrolizumab plus chemotherapy for head and neck cancer patients: influence of response in combination phase on subsequent maintenance phase.

Ken Saijo, Hiroo Imai, Yuki Kasahara, Ryunosuke Numakura, Reio Ueta, Keiju Sasaki, Yuya Yoshida, Sho Umegaki, Sakura Taniguchi, Kota Ouchi …

Discover oncology 16(1) 479-479 2025年4月7日
Outcomes of Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma: A Study Using Real-World Data.

Tomoyuki Iwasaki, Masanobu Takahashi, Kota Ouchi, Keigo Komine, Yuki Kasahara, Noriko Takenaga, Shuto Kodera, Shonosuke Wakayama, Ryunosuke Numakura, Reio Ueta …

The Tohoku journal of experimental medicine 2025年2月13日
Pretreatment neutrophil-lymphocyte ratio as a prognostic factor in recurrent/metastatic head and neck cancer treated with pembrolizumab.

Yuki Kasahara, Ken Saijo, Reio Ueta, Ryunosuke Numakura, Keiju Sasaki, Yuya Yoshida, Sakura Taniguchi, Kota Ouchi, Keigo Komine, Hiroo Imai …

Scientific reports 14(1) 28255-28255 2024年11月16日
Nivolumab-induced Thrombotic Thrombocytopenic Purpura in Patients with Gastric Tube Cancer.

Yuya Yoshida, Sakura Toriyabe, Hiroo Imai, Keiju Sasaki, Yuki Kasahara, Kota Ouchi, Ken Saijo, Koichi Onodera, Chikashi Ishioka

Internal medicine (Tokyo, Japan) 63(19) 2667-2671 2024年10月1日
Correlation between Efficacy and Cardiovascular Adverse Events in Patients with Advanced Solid Cancer Who Received VEGF Pathway Inhibitors: Hypertension within the First Eight Weeks is Associated with Favorable Outcomes of Patients Treated with VEGF Pathway Inhibitors.

Yuya Yoshida, Masanobu Takahashi, Keigo Komine, Sakura Taniguchi, Hideharu Yamada, Keiju Sasaki, Sho Umegaki, Yoshifumi Kawamura, Yuki Kasahara, Kota Ouchi …

Internal medicine (Tokyo, Japan) 2024年6月13日
Erratum for Nivolumab-induced Thrombotic Thrombocytopenic Purpura in Patients with Gastric Tube Cancer.

Yuya Yoshida, Sakura Toriyabe, Hiroo Imai, Keiju Sasaki, Yuki Kasahara, Kota Ouchi, Ken Saijo, Koichi Onodera, Chikashi Ishioka

Internal medicine (Tokyo, Japan) 63(24) 3407-3407 2024年
FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma.

Sakura Hiraide Taniguchi, Keigo Komine, Noriko Takenaga, Yuya Yoshida, Keiju Sasaki, Yoshifumi Kawamura, Yuki Kasahara, Kota Ouchi, Hiroo Imai, Ken Saijo …

Anticancer research 43(12) 5699-5704 2023年12月
Comparison of efficacy and safety between carboplatin-etoposide and cisplatin-etoposide combination therapy in patients with advanced neuroendocrine carcinoma, retrospective study.

Hiroo Imai, Ken Saijo, Yoshifumi Kawamura, Shuto Kodera, Keigo Komine, Tomoyuki Iwasaki, Noriko Takenaga, Yuki Kasahara, Kota Ouchi, Hidekazu Shirota …

Oncology 2023年10月30日
Antibiotics May Interfere with Nivolumab Efficacy in Patients with Head and Neck Squamous Cell Carcinoma

Reio Ueta, Hiroo Imai, Ken Saijo, Yoshifumi Kawamura, Shuto Kodera, Keigo Komine, Kota Ouchi, Yuki Kasahara, Sakura Taniguchi, Yuya Yoshida …

Oncology 1-8 2023年9月14日
Distinct role of CD8 cells and CD4 cells in antitumor immunity triggered by cell apoptosis using a Herpes simplex virus thymidine kinase/ganciclovir system.

Sho Umegaki, Hidekazu Shirota, Yuki Kasahara, Tomoyuki Iwasaki, Chikashi Ishioka

Cancer science 114(8) 3076-3086 2023年8月
Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimens.

Ken Saijo, Hiroo Imai, Kota Ouchi, Keiju Sasaki, Yuya Yoshida, Yoshifumi Kawamura, Sakura Taniguchi, Yuki Kasahara, Keigo Komine, Hidekazu Shirota …

Frontiers in oncology 13 1230731-1230731 2023年
Successful treatment of metastatic fibrosarcomatous dermatofibrosarcoma protuberans with imatinib mesylate.

Yumi Kambayashi, Yuki Kasahara, Kentaro Ohuchi, Ryo Amagai, Akira Hashimoto, Yoshihide Asano, Taku Fujimura

Dermatologic therapy 35(10) e15736 2022年10月
Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study.

Hiroo Imai, Ken Saijo, Keigo Komine, Reio Ueta, Ryunosuke Numakura, Shonosuke Wakayama, Sho Umegaki, Sakura Hiraide, Yoshufumi Kawamura, Yuki Kasahara …

Cancer management and research 14 1259-1266 2022年
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation.

Ken Saijo, Hiroo Imai, Hiromichi Katayama, Fumiyoshi Fujishima, Kenichi Nakamura, Yuki Kasahara, Kota Ouchi, Keigo Komine, Hidekazu Shirota, Masanobu Takahashi …

Case reports in oncology 15(2) 762-769 2022年
Contribution of Fcγ receptor IIB to creating a suppressive tumor microenvironment in a mouse model.

Yuki Kasahara, Hidekazu Shirota, Sho Umegaki, Chikashi Ishioka

Cancer immunology, immunotherapy : CII 68(11) 1769-1778 2019年11月
Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors.

Kota Ouchi, Shin Takahashi, Sonoko Chikamatsu, Shukuei Ito, Yoshikazu Takahashi, Sadayuki Kawai, Akira Okita, Yuki Kasahara, Yoshinari Okada, Hiroo Imai …

International journal of clinical oncology 23(4) 790-798 2018年8月
IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model.

Shuku-Ei Ito, Hidekazu Shirota, Yuki Kasahara, Ken Saijo, Chikashi Ishioka

Cancer immunology, immunotherapy : CII 66(11) 1485-1496 2017年11月
The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.

Masahiro Takahashi, Masanobu Takahashi, Keigo Komine, Hideharu Yamada, Yuki Kasahara, Sonoko Chikamatsu, Akira Okita, Shukuei Ito, Kota Ouchi, Yoshinari Okada …

PloS one 12(6) e0179694 2017年

もっとみる

MISC

Three cases of venous thromboembolism in advanced cancer patients

Keigo Komine, Masanobu Takahashi, Sakura Hiraide, Sho Umegaki, Yoshifumi Kawamura, Hideharu Yamada, Akira Okita, Sonoko Chikamatsu, Yuki Kasahara, Yoshinari Okada …

ANNALS OF ONCOLOGY 29 8-8 2018年10月

共同研究・競争的資金等の研究課題

がん患者血液検体を用いた腫瘍免疫における液性免疫の役割の解明と新規治療標的の探索

日本学術振興会科学研究費助成事業若手研究 2022年4月 - 2026年3月

笠原佑記